Peña Duque M A
Departamento de Hemodinámica, Instituto Nacional de Cardiología Ignacio Chávez, INCICH, Juan Badiano No. 1, 14080 México, D.F.
Arch Cardiol Mex. 2001 Jan-Mar;71 Suppl 1:S136-8.
Angiogenesis refers to a process of new vessel formation originated from pre-existent vessels. This mechanisms requires a series of complex events that include pro-angiogenic and anti-angiogenic molecules. Among the angiogenic factors studied are the fibroblast growth factor (FGF) and the vascular endothelial growth factor (VEGF). Recently, great efforts have been made to apply these factors to the treatment of advanced and chronic ischemic heart disease and for peripheral arterial disease. The present paper reviews angiogenic mechanisms as well as experimental and clinical studies reported in the literature.
血管生成是指从已有的血管中形成新血管的过程。这一机制需要一系列复杂的事件,其中包括促血管生成分子和抗血管生成分子。在已研究的血管生成因子中,有成纤维细胞生长因子(FGF)和血管内皮生长因子(VEGF)。最近,人们为将这些因子应用于晚期和慢性缺血性心脏病以及外周动脉疾病的治疗付出了巨大努力。本文综述了文献中报道的血管生成机制以及实验和临床研究。